Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Thorac Surg. 2017 Jul 29;104(4):1221–1230. doi: 10.1016/j.athoracsur.2017.05.011

Figure 5.

Figure 5

Propensity-Matched survival for pN+ atypical carcinoids by use of adjuvant chemotherapy, NCDB 2006–2011.

Estimate Overall Surgery Alone Adjuvant Chemo P value
12-month survival 98.3% (96.4–100%) 97.7% (94.5–100%) 98.9% (96.6–100%)
60-month survival 60.9% (52.4–70.7%) 72.5% (62.4–84.3%) 47.9% (35.7–64.3%)
Median survival 78.3 months 80.8 months 72 months 0.146
NCDB National Cancer Data Base, pN0 pathologically node negative